NantHealth (NASDAQ:NH) Stock Price Up 16.3%

NantHealth Inc (NASDAQ:NH) rose 16.3% during mid-day trading on Monday . The stock traded as high as $0.59 and last traded at $0.57, approximately 339,001 shares were traded during trading. An increase of 62% from the average daily volume of 209,677 shares. The stock had previously closed at $0.49.

NH has been the subject of several research reports. ValuEngine downgraded shares of NantHealth from a “buy” rating to a “hold” rating in a report on Wednesday, September 4th. Cowen set a $1.00 target price on NantHealth and gave the stock a “buy” rating in a report on Monday, August 26th. Finally, Zacks Investment Research cut NantHealth from a “buy” rating to a “hold” rating in a report on Thursday, August 15th.

The stock has a 50 day simple moving average of $0.53 and a two-hundred day simple moving average of $0.69. The company has a market cap of $76.24 million, a price-to-earnings ratio of -0.40 and a beta of 1.12. The company has a debt-to-equity ratio of 70.81, a current ratio of 0.75 and a quick ratio of 0.74.

NantHealth (NASDAQ:NH) last issued its earnings results on Thursday, August 8th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.01). NantHealth had a negative net margin of 191.63% and a negative return on equity of 10,113.15%. The company had revenue of $25.69 million during the quarter, compared to analysts’ expectations of $24.00 million. As a group, research analysts forecast that NantHealth Inc will post -0.53 EPS for the current year.

A hedge fund recently raised its stake in NantHealth stock. Miracle Mile Advisors LLC increased its holdings in NantHealth Inc (NASDAQ:NH) by 154.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 75,000 shares of the company’s stock after acquiring an additional 45,500 shares during the period. Miracle Mile Advisors LLC owned approximately 0.07% of NantHealth worth $39,000 at the end of the most recent quarter. Institutional investors and hedge funds own 3.33% of the company’s stock.

NantHealth Company Profile (NASDAQ:NH)

NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.

Recommended Story: What is a bull market?

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with's FREE daily email newsletter.